TINA.org’s Year in Review 2025
Looking back at our accomplishments
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
Looking back at our accomplishments
What you should know about this digital skills training platform.
See how you stack up.
This jewelry company may string you along.
Consumer complaints worth remembering.